⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28649782 | 1.00 | — | — | |
| SCHEMBL604266 | 0.93 | TYMP (0.40) | — | |
| SCHEMBL15048839 | 0.93 | TYMP (0.40) | — | |
| SCHEMBL2427492 | 0.90 | TYMP (0.39) | — | |
| SCHEMBL11174869 | 0.88 | TYMP (0.38) | — | |
| SCHEMBL11174866 | 0.88 | TYMP (0.38) | — | |
| SCHEMBL1109730 | 0.87 | TYMP (0.41) | — | |
| SCHEMBL5960583 | 0.84 | TYMP (0.39) | — | |
| SCHEMBL5136081 | 0.84 | — | — | |
| SCHEMBL296554 | 0.83 | TYMP (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | disclosed |
| CN-114829556-A | Polymeric surfactant compounds | 路博润公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-110269856-A | Inhibitor of the polysubstituted aromatic compounds as fibrin ferment | 维颂公司 | 2019-09-24 | — | — | CN | disclosed |
| US-20190248781-A1 | COMPOSITIONS OF KINASE INHIBITORS AND THEIR USE FOR TREATMENT OF CANCER AND OTHER DISEASES RELATED TO KINASES | BOSTON BIOMEDICAL INC (US) | 2019-08-15 | — | — | US | disclosed |
| CN-104940200-B | Inhibitor of the polysubstituted aromatic compounds as fibrin ferment | 维颂公司 | 2019-06-28 | — | — | CN | disclosed |
| WO-2018226150-A1 | PYRAZOLOPYRIMIDINE AS MALT-1 INHIBITORS | MEDIVIR AKTIEBOLAG (SE) | 2018-12-13 | — | — | WO | disclosed |
| EP-2970321-B1 | BUPRENORPHINE ANALOGS | PURDUE PHARMA LP (US) | 2018-06-27 | — | — | EP | disclosed |
| EP-3333156-A2 | BENZOMORPHAN ANALOGS AND THE USE THEREOF | Purdue Pharma L.P. (US) | 2018-06-13 | — | — | EP | disclosed |
| US-9975854-B2 | Benzomorphan analogs and use thereof | PURDUE PHARMA L.P. (US) | 2018-05-22 | — | — | US | disclosed |
| EP-2917182-B1 | BENZOMORPHAN ANALOGS AND THE USE THEREOF | PURDUE PHARMA LP (US) | 2018-01-03 | — | — | EP | disclosed |
| EP-2917182-A2 | BENZOMORPHAN ANALOGS AND THE USE THEREOF | Purdue Pharma LP (US) | 2015-09-16 | — | — | EP | disclosed |
| EP-2858976-A1 | BENZOMORPHAN COMPOUNDS AS OPIOID RECEPTORS MODULATORS | Purdue Pharma LP (US) | 2015-04-15 | — | — | EP | disclosed |
| WO-2014140784-A2 | BUPRENORPHINE ANALOGS | PURDUE PHARMA L.P. (US) | 2014-09-18 | — | — | WO | disclosed |
| US-20140128346-A1 | PHOSPHORUS-SUBSTITUTED QUINOXALINE-TYPE PIPERIDINE COMPOUNDS AND USES THEREOF | PURDUE PHARMA L.P. (US) | 2014-05-08 | — | — | US | disclosed |
| WO-2013167963-A1 | BENZOMORPHAN COMPOUNDS AS OPIOID RECEPTORS MODULATORS | PURDUE PHARMA L.P. (US) | 2013-11-14 | — | — | WO | disclosed |
| WO-2010107384-A1 | ASPARTYL PROTEASE INHIBITORS | MEDIVIR AB (SE) | 2010-09-23 | — | — | WO | disclosed |
| WO-2010042030-A1 | ASPARTYL PROTEASE INHIBITORS | MEDIVIR AB (SE) | 2010-04-15 | — | — | WO | disclosed |
| WO-2009053277-A1 | ASPARTYL PROTEASE INHIBITORS | MEDIVIR AB (SE) | 2009-04-30 | — | — | WO | disclosed |
| WO-2008100547-A2 | COMPOSITIONS COMPRISING LAMIRIDOSIN, IRIDOIDS OR DERIVATIVES THEREOF FOR TREATMENT OF HEPATITIS C OR HEPATITIS B | NY FINANCIAL (INTERNATIONAL) CORPORATION (VG) | 2008-08-21 | — | — | WO | disclosed |
| US-20060247303-A1 | 7H-dibenzo[b,g][1,5]dioxocin-5-one derivatives and use thereof | BAYER HEALTHCARE AG (DE) | 2006-11-02 | — | — | US | disclosed |